New Study Sheds Light on Impact of Fluvoxamine on COVID Symptoms in Certain Cases

ReachMD Healthcare Image


New Study on Fluvoxamine's Impact on COVID Symptoms

New Study Sheds Light on Impact of Fluvoxamine on COVID Symptoms in Certain Cases

Fluvoxamine, a commonly prescribed antidepressant, has been found to potentially reduce the severity of COVID-19 symptoms in certain cases, according to a recent study. The study, conducted by a team of researchers, aimed to investigate the effects of fluvoxamine on COVID-19 patients and provide insights into its potential as a treatment option.


COVID-19, caused by the novel coronavirus SARS-CoV-2, has affected millions of people worldwide since its emergence in late 2019. The disease can range from mild to severe, with some patients experiencing severe respiratory distress and other complications. As researchers continue to explore potential treatments, repurposing existing drugs has become an area of interest.

The Study

The study involved a randomized, double-blind, placebo-controlled trial with a total of 120 COVID-19 patients. Half of the participants received fluvoxamine, while the other half received a placebo. The researchers monitored the patients' symptoms and assessed their clinical outcomes over a period of 15 days.

The results of the study showed that patients who received fluvoxamine experienced a significant reduction in the severity of their symptoms compared to those who received the placebo. The drug was particularly effective in patients with mild to moderate symptoms, with a notable decrease in the risk of clinical deterioration.

Possible Mechanisms

While the exact mechanisms by which fluvoxamine may impact COVID-19 symptoms are not yet fully understood, researchers speculate that the drug's anti-inflammatory and immunomodulatory properties could play a role. Fluvoxamine has been shown to reduce the production of pro-inflammatory cytokines, which are known to contribute to the cytokine storm observed in severe COVID-19 cases.

Implications and Future Research

The findings of this study provide valuable insights into the potential benefits of fluvoxamine in managing COVID-19 symptoms, particularly in patients with mild to moderate cases. However, further research is needed to confirm these results and determine the optimal dosage and treatment duration.

It is important to note that fluvoxamine should not be used as a self-medication for COVID-19 without proper medical guidance. Patients should consult their healthcare providers before considering any new treatments.


The new study on fluvoxamine's impact on COVID-19 symptoms offers promising results and highlights the potential of repurposing existing drugs for the management of this global pandemic. As researchers continue to explore various treatment options, it is crucial to conduct further studies to validate these findings and ensure the safety and efficacy of any potential treatments.

© Article Copyright 1999-2023

Life Technology™


If you would like to republish the content of this or any other article from for commercial purposes visit

Life Technology™ News Content Syndication Licence

. If you would like to republish the content of this or any other article from for non commercial purposes visit

Copyright And Royalty Free RSS Feeds For Commercial And Non Commercial Use


If you would like for us to publish your article at visit

Publish Your Article At Life Technology™

. If you would like to advertise here and on all 100,000+ pages of visit

Advertise At Life Technology™

. For corporate sponsorship of visit

Corporate Sponsorship


Since 1999 Life Technology™ has published medical science and technology news content totally free of charge. Because we do not charge a subscription fee we would kindly request that you

Make A Donation To Life Technology™

and please, do share this article with your coworkers, friends, family and favorite social media platform.

  • The myopia epidemic: Blame computers not phones for short-sightedness, researcher says
  • Study investigates using telemedicine for flu diagnosis
  • New target identified for pulmonary hypertension treatment
  • Could eating turkey ease colitis? Study suggests extra tryptophan could reduce risk of future flares
  • Study finds risk factors for severe COVID-19 cases in children
  • Using Pacman to study cooperative behavior
  • Apotransferrin shows promise as an early treatment for stroke
  • Nut consumption may enhance fertility for men, suggests study
  • 4 out of 5 Mexicans who got a flu shot this year turned down Cuban and Russian COVID-19 vaccines
  • Biomaterial proves capable of accelerating bone regeneration
  • COVID-19 variant maintains threat: WHO
  • AI and synthetic patients to improve diagnosis of chronic fatigue syndrome
  • Unraveling autism spectrum disorder mechanisms through rigid-autonomous phase sequences
  • Investigating parental age effect on the longevity and healthspan of flies and worms
  • Researchers illuminate the complexity of the human hypothalamus
  • Infectious disease researcher discusses the spread, treatment, prevention of drug-resistant Salmonella
  • A sugar tax in Germany could save as much as 16 billion euros and improve population health
  • Bone growth drug may reduce sudden infant death syndrome in children with common form of dwarfism
  • Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues
  • Research finds sex differences in immune response and metabolism drive Alzheimer's disease
  • Promising target for CAR T cells helps cancer trick the immune system
  • New study reveals unexpected consequences of CRISPR-Cas9 gene editing
  • Keep telehealth alive and well, experts tell Senate subcommittee
  • New report highlights increase in number of children and young people with eating disorders
  • More deaths than malaria and HIV/AIDS: What Africa is doing to fight the silent epidemic of antibiotic resistance
  • Merging rural and urban ACA rating areas improved health insurance choice and premiums for rural consumers in Texas
  • Researchers help unravel brain processes involved in vision
  • Using human stem cells to model a severe epilepsy syndrome and identify a potential targeted treatment
  • A year after Pakistan's floods, 44% of children have stunted growth. What can be done about it?
  • Researcher finds help for Alzheimer's-associated agitation with new FDA-approved treatment
  • For veterans receiving dialysis, unstable housing linked to mortality
  • Low income decreases odds of cardiologist involvement in heart failure hospital care
  • Research shows wastewater testing improves predictions for COVID-19 hospital admissions
  • Direct-acting antivirals still underused in hep C-related liver cancer
  • Hemoglobin glycation index is novel risk factor for incident CKD
  • One death, 10 hospitalizations in listeria outbreak tied to peaches, plums
  • High-fiber food advice welcomed by older people, finds study
  • What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?
  • Machine learning could improve efficiency of X-ray-guided pelvic fracture surgery
  • Vitamin B2 derivatives can alleviate chronic kidney inflammation, research suggests
  • Psychological distress reported for indolent non-Hodgkin lymphomas
  • Food insecurity in seniors linked to increased risk for dementia
  • Study: High blood pressure increasing in low-income adults, while diabetes, obesity on the rise in higher-income adults
  • Long COVID happens in nursing homes, too, study finds
  • Researchers uncover role of 'molecular plasters' that protect against infection
  • Malaria: Two groundbreaking vaccines have been developed, but access and rollout are still big stumbling blocks
  • Early births—between 34 and 37 weeks—for moms with pre-eclampsia can reduce baby and mother deaths
  • Study uncovers prevalence of diabetes among American Indian and Alaska Native communities
  • How movies use music to manipulate your memory
  • New drug delivery system could reduce daily diabetes shots to just three a year

  • Life Technology™ Medical NewsFeedburnerGoogleRSSLife Technology™ Science NewsFeedburnerGoogleRSSLife Technology™ Technology NewsFeedburnerGoogleRSS

    Facebook Comments


    We’re glad to see you’re enjoying Omnia Education…
    but how about a more personalized experience?

    Register for free